## Review setup
- **Input scope** Abstract only
- **Assessment boundary** Claims and evidence presented in the abstract, as supplied
- **Shared manuscript claim summary** The authors propose that CCDC124 is a highly disordered protein with low-complexity N-terminal regions and a central aggregation sequence (151-IAVLSV-156), that residue V153 contributes to dimeric/oligomeric assembly, and that CCDC124 forms cytoplasmic dimers as confirmed by co-immunoprecipitation, immunostaining, and bimolecular fluorescence complementation.
- **Visible evidence base** Abstract text only; no figures, tables, methods, or supplementary data provided
- **Missing materials affecting confidence** Full manuscript, all experimental protocols, statistical analyses, raw imaging data, docking scores, binding free energy values, and validation of the in silico model

## Reviewer
- **Overall assessment** The abstract presents a plausible but incompletely supported narrative linking sequence features of CCDC124 to its aggregation and dimerization behavior. The combination of computational prediction and three experimental methods is commendable in principle, but the abstract lacks quantitative results, controls, and methodological detail necessary to evaluate the strength of the claims. The central conclusion that low-complexity regions regulate aggregate formation is speculative and not directly tested.
- **Who would be interested in the results, and why** Researchers studying intrinsically disordered proteins, ribosome-associated factors, and protein aggregation mechanisms would find the characterization of CCDC124 useful. Those interested in the structural basis of ribosomal hibernation and translational control may also follow this work, though the functional link to aggregation is not established here.
- **Major strengths** The study addresses a poorly characterized protein with potential regulatory importance. The use of multiple orthogonal methods (in silico prediction, co-immunoprecipitation, immunostaining, BiFC) to probe dimerization is a reasonable strategy. The identification of a specific aggregation-prone sequence and a candidate residue (V153) provides a testable hypothesis.
- **Major Concerns** 
  - R1-M1
  - R1-M2
  - R1-M3
- **Minor Comments** 
  - R1-m1
  - R1-m2
  - R1-m3
- **Technical failings that need to be addressed before the case is established** The abstract does not report any quantitative data (e.g., binding energies, colocalization coefficients, BiFC fluorescence intensities) or negative controls. The in silico model is not validated against experimental structures or evolutionary conservation. The claim that low-complexity regions regulate aggregation is not supported by any direct mutagenesis or deletion experiment.
- **Assessment against Nature-style criteria** 
  - Originality: Moderate. The protein is new to structural characterization, but the approach (disorder prediction plus dimerization assays) is standard.
  - Scientific importance: Limited at this stage. The functional consequences of CCDC124 dimerization or aggregation are not demonstrated.
  - Interdisciplinary readership: Narrow. The abstract is primarily of interest to structural biologists and protein chemists.
  - Technical soundness: Not assessable from the abstract alone. Key experimental details and statistical treatments are absent.
  - Readability for nonspecialists: Acceptable but dense. The abstract assumes familiarity with ribosomal hibernation and BiFC.
- **Recommendation posture** Currently not established from the provided evidence. The abstract suggests a promising direction, but the claims require substantial additional data and controls before the case is convincing.

### Major Concerns

- **Concern ID** R1-M1
- **Severity** Major
- **Blocking** Yes
- **Axis** Evidence sufficiency
- **Claim pointer** The authors claim that molecular docking and post-docking binding free energy analyses highlight a potential involvement of V153 in generating high-order dimeric/oligomeric structures.
- **Evidence pointer** Abstract, location not provided
- **Concern** No numerical values, docking scores, or free energy differences are reported. The phrase "potential involvement" is vague and does not indicate whether V153 was tested by mutation or whether the effect is statistically significant relative to other residues.
- **Why it matters** Without quantitative support, the reader cannot judge whether V153 is a genuine driver of oligomerization or merely one of many residues in a predicted interface. This claim is central to the mechanistic interpretation.
- **Resolution test** Provide the docking scores, binding free energy values with errors, and a comparison to alanine-scanning or other residue substitutions. Show that V153 mutation disrupts dimerization in a functional assay.

- **Concern ID** R1-M2
- **Severity** Major
- **Blocking** Yes
- **Axis** Experimental validation
- **Claim pointer** The authors state that co-immunoprecipitation, immunostaining, and BiFC analyses confirm the dimeric state of CCDC124 predominantly localized at the cytoplasm.
- **Evidence pointer** Abstract, location not provided
- **Concern** The abstract does not describe any controls (e.g., negative transfection, competition with a non-dimerizing mutant, or a known monomeric control). Immunostaining alone cannot distinguish dimers from higher-order aggregates, and BiFC requires careful controls for false positives due to overexpression.
- **Why it matters** Dimerization is the core experimental claim. Without proper controls and quantification, the conclusion is not robust. The abstract also does not specify whether the observed cytoplasmic signal represents soluble dimers or insoluble aggregates.
- **Resolution test** Include a negative control (e.g., a truncation mutant lacking the aggregation sequence), quantify BiFC fluorescence across multiple fields, and show that the cytoplasmic signal is not due to aggregated inclusion bodies.

- **Concern ID** R1-M3
- **Severity** Major
- **Blocking** Yes
- **Axis** Claim support
- **Claim pointer** The authors conclude that low-complexity regions located at the N-terminus of disordered CCDC124 may regulate the formation of aggregates or high-order dimeric/oligomeric states.
- **Evidence pointer** Abstract, location not provided
- **Concern** This is a speculative conclusion. No experiment directly tests the role of the N-terminal low-complexity regions. The abstract does not report any deletion, mutation, or chimeric construct that would link these regions to aggregation propensity.
- **Why it matters** The title and conclusion hinge on this regulatory role. Without direct evidence, the statement is an untested hypothesis presented as a finding.
- **Resolution test** Generate N-terminal deletion or substitution mutants and compare their aggregation and dimerization behavior to the wild-type protein using the same assays.

### Minor Comments

- **Concern ID** R1-m1
- **Severity** Minor
- **Axis** Clarity
- **Affected element** Abstract wording
- **Evidence pointer** Abstract, location not provided
- **Issue** The phrase "high-order dimeric/oligomeric states" is ambiguous. It is unclear whether the authors mean dimers that can further oligomerize or a mixture of dimeric and higher-order species.
- **Required correction** Define the term explicitly, for example, "dimers and higher-order oligomers" or "a dimer that serves as a building block for larger assemblies."

- **Concern ID** R1-m2
- **Severity** Minor
- **Axis** Methodological transparency
- **Affected element** In silico modeling
- **Evidence pointer** Abstract, location not provided
- **Issue** The abstract does not specify which in silico tools were used for structure prediction, disorder analysis, or docking. This limits reproducibility.
- **Required correction** List the software and versions used, and state whether the model was validated against known structural homologs or experimental data.

- **Concern ID** R1-m3
- **Severity** Minor
- **Axis** Functional relevance
- **Affected element** Biological interpretation
- **Evidence pointer** Abstract, location not provided
- **Issue** The abstract does not connect the observed dimerization or aggregation to any functional consequence for ribosomal hibernation or translational control, which are the protein's known roles.
- **Required correction** Add a sentence discussing whether the dimeric state is required for ribosome binding or whether aggregation is a regulatory mechanism, or explicitly state that this remains unknown.

## Risk / unsupported claims
- The claim that V153 is involved in oligomerization is unsupported without quantitative docking data or mutagenesis.
- The claim that low-complexity regions regulate aggregate formation is unsupported by any direct experiment.
- The claim that CCDC124 is "predominantly localized at the cytoplasm" is not supported by quantitative imaging data or colocalization statistics.
- The overall conclusion that dimerization underlies aggregation propensity is not established, as the abstract does not demonstrate a causal link between the two phenomena.